Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Tracking successive Wallerian degenerations in a relapsing-remitting multiple sclerosis patient.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents.
Segmenting and Validating Brain Tissue Definitions in the Presence of Varying Tissue Contrast.
A large fraction of neocortical myelin ensheathes axons of local inhibitory neurons.
The spectrum of leukodystrophies in children: Experience at a tertiary care centre from North India.
Repair and regeneration of lumbosacral nerve defects in rats with chitosan conduits containing bone marrow mesenchymal stem cells.
Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder.
Web-based physiotherapy for people moderately affected with Multiple Sclerosis; quantitative and qualitative data from a randomized, controlled pilot study.
Major histocompatibility complex haplotype RT1av1 is associated with relapsing/remitting experimental autoimmune encephalomyelitis.
Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases.
The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
Gene expression profiling in multiple sclerosis brain.
Prognosis in multiple sclerosis and the unveiling of pathogenic clues.
Developmental changes in plasticity, synaptic, glia and connectivity protein levels in rat dorsal hippocampus.
Neurofascin-155 as a putative antigen in combined central and peripheral demyelination.
Electrical and Network Neuronal Properties Are Preferentially Disrupted in Dorsal, But Not Ventral, Medial Entorhinal Cortex in a Mouse Model of Tauopathy.
miRNAs Participate in MS Pathological Processes and Its Therapeutic Response.
Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK/SIRT1 signaling pathway and Th17/Treg immune response.
Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.
Multiple sclerosis among Iranian-Arabs and Persians of Khuzestan: Is there any ethnic difference?
Cerebrovascular pattern improved by ozone autohemotherapy: an entropy-based study on multiple sclerosis patients.
Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals.
Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients.
Biological therapy and neurological manifestations. What do we know?
Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children.
Pages
« first
‹ previous
…
690
691
692
693
694
695
696
697
698
…
next ›
last »